Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021

Affiliations

• ¹ School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
• ² Department of Population Medicine, Harvard Pilgrim Healthcare Institute and Harvard Medical School, Boston, MA.
• ³ Sydney Pharmacy School, The University of Sydney, Sydney, NSW, Australia.
• ⁴ Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Sydney, NSW, Australia.